Project Grant K99HL185935
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $169,020 to the University of Pennsylvania on September 1, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to support a five-year research and training initiative through August 31, 2030. This Project Grant funds a structured career development program for a postdoctoral fellow to advance independent research capabilities focused on understanding endothelial-immune...
- Federal Project Grant Award Summary The University of Pennsylvania received a $1,351,359 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective July 1, 2025, through March 31, 2030. The award funds research investigating alveolar epithelial stress signaling mechanisms in pulmonary fibrosis, a progressive and devastating lung disease with limited therapeutic options. The research employs complementary in...
- Federal Grant Award Summary The University of Pennsylvania received a $701,795 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through June 30, 2029. This research project, titled "Defining Cardinal Functions of Lung Progenitors During Regeneration," delivers comprehensive scientific investigation into lung tissue repair mechanisms and their dysfunction in chronic...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Pennsylvania a $629,498 Project Grant on September 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct research on pediatric interstitial lung disease (CHILD) mechanisms and targeted therapies. The award, which extends through June 30, 2030, funds the development and utilization of preclinical models—including an in vivo mouse model of surfactant...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $156,168 to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center for research exploring the role of the Hedgehog pathway-primary cilia axis in human lung alveolarization and disease under the Cardiovascular Diseases Research program (CFDA 93.837). The two-year project, initiated August 1, 2025 and concluding July 31, 2027, investigates how hedgehog signaling regulates alveolar...
- This five-year Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research career development focused on neonatal respiratory progenitor cell function in hyperoxic conditions. Awarded to The Trustees of Columbia University in the City of New York on September 1, 2025, with total obligated funds of $166,395 and completion scheduled for August 31, 2030, the grant funds an Assistant Professor in...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant of $174,744 to the University of California, San Francisco on June 2, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support fundamental research on acute lung injury modulation. The research investigates the immunoregulatory role of the phosphatase SHP1 (Src Homology Region 2 Domain-Containing Phosphatase-1) in acute respiratory distress syndrome and acute lung injury, with the ultimate...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Trustees of Boston University a Project Grant of $166,752 (Award Date: September 1, 2025; Completion Date: August 31, 2027) under the Cardiovascular Diseases Research program (CFDA 93.837) to advance understanding of lung branching morphogenesis through synthetic biology approaches. The research deliverables will include fundamental discoveries regarding the signaling mechanisms—specifically...
- Federal Grant Award Summary The University of Pennsylvania received a $169,020 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 19, 2025, with completion targeted for August 31, 2027. This research project focuses on decoding nuclear mechanosignaling and epigenetic mediators of mechanical memory in cardiomyocytes—the process by which cardiac cells convert external mechanical signals into...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant totaling $173,259 to the University of California, San Diego, with a performance period from September 1, 2025, through August 31, 2028, under the Cardiovascular Diseases Research program (CFDA 93.837). This grant supports fundamental research investigating the role of Kruppel-like factor-6 (KLF6) in lung development. The principal investigator will conduct research to delineate KLF6's...
The National Heart, Lung, and Blood Institute awarded a $157,658 Project Grant to the University of Pennsylvania effective June 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support research through May 31, 2028. This award funds a K99/R00 career development project investigating the mechanical regulation of the lung gas exchange interface, specifically examining how mechanical forces during breathing influence cellular behavior within the alveoli. The research will elucidate molecular mechanisms governing the specification and maintenance of mechanically induced capillary endothelial cells (miCAPs) identified through a novel reversible bronchial ligation model in mice. During the K99 training phase, the investigator will define the molecular drivers of miCAP fate at the University of Pennsylvania's research facilities. During the subsequent R00 phase, the project will leverage newly developed transgenic mouse lines to conduct lineage tracing studies examining how mechanically sensitive cells respond to pathological mechanical forces during acute lung injury. Completion of these research aims is expected to provide critical insights into how mechanical forces regulate lung structure and function, with implications for understanding acute lung injury and other mechanical disruption-related lung diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $157.7k | 6/18/26 |